Meng Zheng

About Meng Zheng

Meng Zheng, With an exceptional h-index of 35 and a recent h-index of 30 (since 2020), a distinguished researcher at Henan University, specializes in the field of biomaterials, nanomedicine, siRNA delivery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cell Membrane Camouflaged Biomimetic Nanoparticles as a Versatile Platform for Brain Diseases Treatment

Brain Targeted Strategies of Oligonucleotide Drug for Aging-associated Diseases Therapy

Nano-structural Protein Degradation Tool, Use, and Preparation Method thereof, and Lipid-based Protein Degradation Tool, Use, and Preparation Method thereof

Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment (vol 32, 2000416, 2020)

Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis

Exosomes based strategies for brain drug delivery

Meng Zheng Information

University

Position

___

Citations(all)

3978

Citations(since 2020)

2862

Cited By

1883

hIndex(all)

35

hIndex(since 2020)

30

i10Index(all)

53

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Meng Zheng Skills & Research Interests

biomaterials

nanomedicine

siRNA delivery

Top articles of Meng Zheng

Cell Membrane Camouflaged Biomimetic Nanoparticles as a Versatile Platform for Brain Diseases Treatment

2022/3/1

Brain Targeted Strategies of Oligonucleotide Drug for Aging-associated Diseases Therapy

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

2024/2/1

Yang Liu
Yang Liu

H-Index: 18

Meng Zheng
Meng Zheng

H-Index: 23

Nano-structural Protein Degradation Tool, Use, and Preparation Method thereof, and Lipid-based Protein Degradation Tool, Use, and Preparation Method thereof

2024/2/1

Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment

Nature Communications

2023/7/28

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment (vol 32, 2000416, 2020)

Advanced Materials

2020/6

Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma

Nano Today

2023/4/1

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis

Nature Communications

2023/3/22

Exosomes based strategies for brain drug delivery

2023/2/1

Yang Liu
Yang Liu

H-Index: 18

Meng Zheng
Meng Zheng

H-Index: 23

Brain-targeted codelivery of Bcl-2/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy

ACS nano

2022/3/30

Preparation and Evaluation of siRNAsome as siRNA and Drug Delivery System

2022/1/4

Hybrid membrane camouflaged nanomedicine loaded with oxidative phosphorylation inhibitor and preparing method thereof

2022/12/1

Brain‐Targeting Metastatic Tumor Cell Membrane Cloaked Biomimetic Nanomedicines Mediate Potent Chemodynamic and RNAi Combinational Therapy of Glioblastoma

Advanced Functional Materials

2022/12

A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor

Advanced Therapeutics

2022/12

Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma

Nature Communications

2022/11/11

Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy

Journal of Controlled Release

2022/11/1

Gene Editing Nanocapsule and Preparation Method and Use Thereof

2022/10/13

Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition

Biomaterials

2022/10/1

Targeted Protein Degradation via Nanoparticles

bioRxiv

2022/9/22

Back Cover: Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy (EXP2 4/2022)

Exploration

2022/8

Brain co‐delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy

Advanced Materials

2022/8

See List of Professors in Meng Zheng University(Henan University)

Co-Authors

academic-engine